Medicare Enrolled
Dr. Raul Roth, M.D.
Cardiovascular Disease · Pasadena, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Roth from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Roth?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Roth
Dr. Raul Roth is a cardiovascular disease specialist in Pasadena, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Roth performed 6,412 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Roth received a total of $7,364 from 40 pharmaceutical and/or device companies across 395 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Roth is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 14% volume in CA
$7,364 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗6,412
Medicare services
Top 14% in CA for cardiovascular disease
Not available
Unique patients (not deduplicated)
$71
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
877 | $47 | $223 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
664 | $43 | $170 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
648 | $102 | $250 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
635 | $143 | $758 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
577 | $12 | $80 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
430 | $7 | $61 |
| Remote vital sign monitoring management, each additional 20 minutes This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period. |
420 | $35 | $135 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
413 | $102 | $325 |
| Psychiatric collaborative care follow-up, first 60 minutes A follow-up psychiatric care management visit for subsequent calendar months. The service covers the first 60 minutes of collaborative care coordination. |
323 | $124 | $511 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
294 | $69 | $175 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
149 | $133 | $425 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
145 | $68 | $225 |
| Psychiatric collaborative care management, additional 30 minutes This code covers each additional 30 minutes of psychiatric collaborative care management provided per calendar month. |
129 | $51 | $195 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
109 | $149 | $600 |
| Remote physiologic monitoring setup and education Initial setup of remote monitoring equipment and patient education on its use. |
86 | $18 | $67 |
| Echocardiogram with color Doppler An ultrasound of the heart that uses color imaging to visualize blood flow, measure flow rate, and assess valve function. |
78 | $13 | $225 |
| Echocardiogram, transthoracic An ultrasound test that uses sound waves to create images of the heart's blood flow, valves, and chambers. |
73 | $33 | $209 |
| Initial psychiatric collaborative care management, first 70 minutes This service covers the first 70 minutes of psychiatric collaborative care management during the initial calendar month of treatment. |
56 | $135 | $513 |
| Stress echocardiogram with ECG monitoring An ultrasound of the heart performed while monitoring heart rhythm during rest, exercise, or medication-induced stress, followed by a review and report of the findings. |
41 | $189 | $1,000 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while an electrocardiogram is monitored under physician supervision. |
38 | $18 | $75 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
38 | $12 | $65 |
| Psychiatric collaborative care management, first 30 minutes This service involves behavioral health manager activities coordinated with a psychiatric consultant and directed by the treating physician. It covers the initial or subsequent care management for the first 30 minutes within a month. |
32 | $52 | $216 |
| Transesophageal echocardiogram An ultrasound of the heart performed using a probe inserted into the esophagus to obtain detailed images of heart structures and function. |
30 | $91 | $500 |
| Heart muscle strain imaging | 26 | $35 | $200 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
25 | $152 | $350 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
20 | $21 | $85 |
| 30-day continuous ECG with patient-triggered event transmission and review This procedure involves continuous electrocardiogram monitoring for up to 30 days, including the transmission of patient-triggered events. A healthcare professional reviews the data and provides a report. |
20 | $799 | $1,200 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
13 | $56 | $375 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
12 | $106 | $425 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
11 | $65 | $795 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
11.0% high complexity
4.3% medium
84.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$7,364
Total received (2018-2024)
Avg $1,052/year across 7 years
Top 33% in CA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
40
Companies
395
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,062
2023
$921
2022
$1,451
2021
$1,285
2020
$496
2019
$1,023
2018
$1,125
Payments by company (2024)
PFIZER INC.
$231
Novartis Pharmaceuticals Corporation
$231
E.R. Squibb & Sons, L.L.C.
$131
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$59
Novo Nordisk Inc
$43
ABIOMED
$38
Esperion Therapeutics, Inc.
$30
Lilly USA, LLC
$29
Merck Sharp & Dohme LLC
$27
Boston Scientific Corporation
$26
Inspire Medical Systems, Inc.
$24
Alnylam Pharmaceuticals Inc.
$24
Janssen Pharmaceuticals, Inc
$23
Celgene Corporation
$20
Amgen Inc.
$20
Abbott Laboratories
$20
Boehringer Ingelheim Pharmaceuticals, Inc.
$20
AstraZeneca Pharmaceuticals LP
$19
Kestra Medical Technology Services, Inc.
$17
Kiniksa Pharmaceuticals International, plc
$16
HEARTFLOW, INC.
$15
Top 3 companies account for 55.8% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$1,775
Amgen Inc.
$1,233
PFIZER INC.
$966
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$530
Janssen Pharmaceuticals, Inc
$329
E.R. Squibb & Sons, L.L.C.
$291
Abbott Laboratories
$255
BOSTON SCIENTIFIC CORPORATION
$200
Boehringer Ingelheim Pharmaceuticals, Inc.
$188
Alnylam Pharmaceuticals Inc.
$144
Esperion Therapeutics, Inc.
$132
Merck Sharp & Dohme LLC
$130
AstraZeneca Pharmaceuticals LP
$119
Kiniksa Pharmaceuticals, Ltd.
$115
Medtronic Vascular, Inc.
$115
Gilead Sciences, Inc.
$98
Novo Nordisk Inc
$85
Boston Scientific Corporation
$83
Actelion Pharmaceuticals US, Inc.
$50
Impulse Dynamics (USA) Inc.
$48
Kestra Medical Technology Services, Inc.
$48
Amarin Pharma Inc.
$41
ABIOMED
$38
Lilly USA, LLC
$29
Bayer HealthCare Pharmaceuticals Inc.
$28
Edwards Lifesciences Corporation
$25
Otsuka America Pharmaceutical, Inc.
$25
Inspire Medical Systems, Inc.
$24
SANOFI-AVENTIS U.S. LLC
$23
Akcea Therapeutics, Inc.
$23
Regeneron Healthcare Solutions, Inc.
$21
iRhythm Technologies, Inc.
$21
Celgene Corporation
$20
United Therapeutics Corporation
$19
SCPHARMACEUTICALS INC.
$17
Allergan Inc.
$16
ATRICURE, INC.
$16
Kiniksa Pharmaceuticals International, plc
$16
HEARTFLOW, INC.
$15
Philips Electronics North America Corporation
$15
Top 3 companies account for 54.0% of all-time payments
Associated products mentioned in payments ›
(7999) SRC Undivided · AMVUTTRA · ATRICLIP LAA EXCLUSION SYSTEM · Arcalyst · Arctic Front · Assure WCD · BYSTOLIC · CAMZYOS · CARDIOMEMS · CardioMEMS HF System · Corlanor · ELIQUIS · ENTRESTO · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · FARXIGA · FFRct · FUROSCIX · INSPIRE · Impella · JARDIANCE · Kerendia · LEQVIO · LifeVest · MULTAQ · Merlin Connectivity and Remote · Mitra Clip system · MyCareLink · NEXLETOL · ONPATTRO · OPSUMIT · OPSUMIT MACITENTAN · Optimizer · Ozempic · PRADAXA · PRALUENT ALIROCUMAB INJECTION · Repatha · Rybelsus · SAMSCA · SQRX PULSE GENERATOR · Sentinel · TEGSEDI · TYVASO · VERQUVO · VYNDAQEL · Vascepa · WAINUA · WATCHMAN · XARELTO · ZEPBOUND · ZIO XT Patch
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Cardiologists in nearby ZIP areas
590
County median income
$87,760
Nearest hospital to ZIP centroid (approximate)
GLENDALE ADVENTIST MEDICAL CENTER
3.1 mi
3.1 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Roth is a clinical cardiology specialist, with above-average Medicare volume (top 14% in CA), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Roth experienced with remote patient monitoring device, 30 days?
Based on Medicare claims data, Dr. Roth performed 877 remote patient monitoring device, 30 days services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Roth receive payments from pharmaceutical companies?
Yes. Dr. Roth received a total of $7,364 from 40 companies across 395 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Roth's costs compare to other cardiologists in Pasadena?
Dr. Roth's average Medicare payment per service is $71. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Roth) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Pasadena
Browse cardiologists in Pasadena ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in CA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in CA
Which CA cardiologists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology